Evidence map›Paper›PMID 23483047›Full record

ArticleCardiovascular research2013

Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

Paolo Poggio, Rachana Sainger, Emanuela Branchetti, Juan B Grau, Eric K Lai, Robert C Gorman, Michael S Sacks, Alessandro Parolari, Joseph E Bavaria, Giovanni Ferrari

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease.Frontiers in cell and developmental biology · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Porphyrin-Based SOD Mimic MnTnBu OE -2-PyPJournal of the American Heart Association · 2018
    Article
  13. [Role of neuropeptide substance P and the bone morphogenetic protein signaling pathway in osteogenic differentiation of ST2 cells].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Role for Galectin-3 in Calcific Aortic Valve Stenosis.Journal of the American Heart Association · 2016
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Paolo PoggioPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Rachana Sainger
Emanuela Branchetti
Juan B Grau
Eric K Lai
Robert C Gorman
Michael S Sacks
Alessandro Parolari
Joseph E Bavaria
Giovanni Ferrari
University of Pennsylvania · USThe University of Texas at Austin · USUniversity of Milan · IT

Funding

Echocardiography to Predict Recurrent IMR After Surgical Mitral Valve ReplacementR01HL103723 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI GORMAN, ROBERT C, HUNG, JUDY W · 2011 to 2020
$5.3M
Osteopontin: a Novel Biomarker for Calcific Aortic Valve DiseasesRC1HL100035 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FERRARI, GIOVANNI · 2009 to 2010
$999k
NHLBI NIH HHS R01 HL103723NHLBI NIH HHS RC1HL100035
6 · The paper itself

Abstract

aimsAortic valve sclerosis (AVSc) is a hallmark of several cardiovascular conditions ranging from chronic heart failure and myocardial infarction to calcific aortic valve stenosis (AVS). AVSc, present in 25-30% of patients over 65 years of age, is characterized by thickening of the leaflets with marginal effects on the mechanical proprieties of the valve making its presentation asymptomatic. Despite its clinical prevalence, few studies have investigated the pathogenesis of this disease using human AVSc specimens. Here, we investigate in vitro and ex vivo BMP4-mediated transdifferentiation of human valve interstitial cells (VICs) towards an osteogenic-like phenotype in AVSc. METHODS AND

resultsHuman specimens from 60 patients were collected at the time of aortic valve replacement (AVS) or through the heart transplant programme (Controls and AVSc). We show that non-calcified leaflets from AVSc patients can be induced to express markers of osteogenic transdifferentiation and biomineralization through the combinatory effect of BMP4 and mechanical stimulation. We show that BMP4 antagonist Noggin attenuates VIC activation and biomineralization. Additionally, patient-derived VICs were induced to transdifferentiate using either cell culture or a Tissue Engineering (TE) Aortic Valve model. We determine that while BMP4 alone is not sufficient to induce osteogenic transdifferentiation of AVSc-derived cells, the combinatory effect of BMP4 and mechanical stretch induces VIC activation towards a phenotype typical of late calcified stage of the disease.

conclusionThis work demonstrates, for the first time using AVSc specimens, that human sclerotic aortic valves can be induced to express marker of osteogenic-like phenotype typical of advanced severe aortic stenosis.

Indexed as

OsteogenesisAdultAgedAged, 80 and overAortic ValveAortic Valve StenosisBioreactorsBone Morphogenetic Protein 4CalcinosisCarrier ProteinsCase-Control StudiesCells, CulturedCell TransdifferentiationDisease ProgressionFemaleGene Expression RegulationBMP4 protein, humanBone Morphogenetic Protein 4Carrier ProteinsNoggin ProteinRecombinant ProteinsAortic valve sclerosisBone morphogenetic protein 4Calcific aortic stenosisValve interstitial cells

Identifiers

PMID23483047
PMCPMC3656614
OpenAlexW1971552389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.